Claudia Sommer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Claudia Sommer has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Carsten Wessig
Neurologische Universitätsklinik Würzburg
2 shared publications - Hermann Einsele
Department of Internal Medicine II, Division of Hematology, University Hospital of Würzburg, Würzburg, Germany
1 shared publication - Kathrin Doppler
Neurologische Klinik, Universitätsklinikum Würzburg, Josef-Schneider-Str. 11, 97080, Würzburg, Germany
1 shared publication - Mathias Mäurer
Caritas Krankenhaus Bad Mergentheim
1 shared publication - Reinhard Kiefer
Neurologische Klinik und Praxis, AGAPLESION Diakonieklinikum Rotenburg gGmbH, Rotenburg (Wümme), Deutschland
1 shared publication - Stefan Knop
Medizinische Klinik und Poliklinik II, Julius Maximilians Universität Würzburg, Würzburg, Germany
1 shared publication
Latest Publications
- 28 October 2013
- Published by Wiley in Muscle & Nerve
- Vol. 48 (6) , 983-988
Sporadic late onset nemaline myopathy and immunoglobulin deposition disease
Introduction: In monoclonal gammopathy, organ dysfunction can occur due to deposition of immunoglobulin fragments. A rare form of acquired myopathy often associated with monoclonal gammopathy is sporadic late onset nemaline myopathy (SLONM), which is characterized by nemaline rods in myofibers. The pathogenetic link between monoclonal gammopathy and SLONM has not yet been elucidated. Methods: Case report of a patient with monoclonal gammopathy who developed a progressive myopathy, finally diagnosed as SLONM. Results: A muscle biopsy showed mild myopathic changes. A second biopsy 1 year after clinical onset demonstrated deposition of immunoglobulin light and heavy chains and the presence of nemaline rods. The patient experienced marked improvement of muscle strength after autologous stem cell transplantation and treatment with bortezomib, a therapy that is known to be effective in light chain deposition disease. Conclusions: We speculate that deposition of light and heavy chains, rather than nemaline bodies, has myotoxic effects on skeletal muscle. Muscle Nerve 48: 983–988, 2013
- 28 October 2013
- Published by Wiley in Muscle & Nerve
- Vol. 48 (6) , 983-988
Sporadic late onset nemaline myopathy and immunoglobulin deposition disease
Introduction: In monoclonal gammopathy, organ dysfunction can occur due to deposition of immunoglobulin fragments. A rare form of acquired myopathy often associated with monoclonal gammopathy is sporadic late onset nemaline myopathy (SLONM), which is characterized by nemaline rods in myofibers. The pathogenetic link between monoclonal gammopathy and SLONM has not yet been elucidated. Methods: Case report of a patient with monoclonal gammopathy who developed a progressive myopathy, finally diagnosed as SLONM. Results: A muscle biopsy showed mild myopathic changes. A second biopsy 1 year after clinical onset demonstrated deposition of immunoglobulin light and heavy chains and the presence of nemaline rods. The patient experienced marked improvement of muscle strength after autologous stem cell transplantation and treatment with bortezomib, a therapy that is known to be effective in light chain deposition disease. Conclusions: We speculate that deposition of light and heavy chains, rather than nemaline bodies, has myotoxic effects on skeletal muscle. Muscle Nerve 48: 983–988, 2013
- 1 January 2012
- Published by Springer Nature
- p. 115-151
Immunneuropathien